Cyclo Therapeutics (CYTH) Stock Chart & Stock Price History → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free CYTH Stock Alerts $1.26 +0.01 (+0.80%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Cyclo Therapeutics Stock Price Performance5 Day Performance-0.79%1 Month Performance-14.29%3 Month Performance-23.64%6 Month Performance-3.08%Year-To-Date Performance-20.75%1 Year Performance-21.25% Receive CYTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cyclo Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. CYTH Stock Chart for Monday, June, 10, 2024 CYTH Chart by TradingView Cyclo Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$1.25$1.26+0.80%$1.28$1.249,076 shs$36.06 million06/06/2024$1.27$1.25-1.57%$1.29$1.2422,529 shs$35.78 million06/05/2024$1.29$1.27-1.55%$1.36$1.11117,473 shs$36.35 million06/04/2024$1.29$1.29$1.35$1.2435,221 shs$36.92 million06/03/2024$1.28$1.29+0.78%$1.33$1.2512,080 shs$36.92 million05/31/2024$1.30$1.28-1.54%$1.37$1.2815,843 shs$36.63 million Get the Latest News and Ratings for CYTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$1.29$1.30+0.78%$1.35$1.2729,350 shs$37.21 million05/29/2024$1.28$1.29+0.78%$1.39$1.2523,144 shs$36.92 million05/28/2024$1.35$1.28-5.19%$1.32$1.2612,537 shs$36.63 million05/27/2024$1.35$1.35$1.42$1.3128,900 shs$38.64 million05/24/2024$1.30$1.35+3.85%$1.42$1.3128,969 shs$38.64 million05/23/2024$1.29$1.30+0.78%$1.37$1.2553,692 shs$37.21 million05/22/2024$1.36$1.29-5.15%$1.33$1.2823,999 shs$36.92 million05/21/2024$1.42$1.36-4.23%$1.47$1.3024,641 shs$38.92 million05/20/2024$1.40$1.42+1.43%$1.49$1.3415,001 shs$40.64 million05/17/2024$1.37$1.40+2.19%$1.40$1.3321,590 shs$40.21 million05/16/2024$1.43$1.37-4.20%$1.44$1.3552,850 shs$39.34 million05/15/2024$1.41$1.43+1.42%$1.47$1.4016,340 shs$41.07 million05/14/2024$1.40$1.41+0.71%$1.54$1.4032,013 shs$40.50 million05/13/2024$1.47$1.40-4.76%$1.49$1.4020,591 shs$40.21 million05/10/2024$1.45$1.47+1.38%$1.54$1.4529,201 shs$42.22 million05/09/2024$1.50$1.45-3.33%$1.59$1.4475,624 shs$41.64 million05/08/2024$1.51$1.50-0.66%$1.55$1.4918,777 shs$43.08 million05/07/2024$1.53$1.51-1.31%$1.58$1.5026,244 shs$43.37 million05/06/2024$1.51$1.53+1.32%$1.62$1.5032,025 shs$43.94 million05/03/2024$1.47$1.51+2.72%$1.55$1.4826,352 shs$43.37 million05/02/2024$1.45$1.47+1.38%$1.50$1.4518,996 shs$42.22 million05/01/2024$1.46$1.45-0.68%$1.50$1.4529,137 shs$41.64 million04/30/2024$1.47$1.46-0.68%$1.48$1.4032,609 shs$41.93 million04/29/2024$1.26$1.47+16.67%$1.47$1.2856,427 shs$42.22 million04/26/2024$1.33$1.30-2.26%$1.35$1.2628,155 shs$37.34 million04/25/2024$1.30$1.33+2.31%$1.33$1.2616,838 shs$38.20 million04/24/2024$1.21$1.30+7.44%$1.31$1.2220,966 shs$37.34 million04/23/2024$1.26$1.21-3.97%$1.28$1.2033,064 shs$34.75 million04/22/2024$1.16$1.26+8.62%$1.32$1.1784,006 shs$36.18 million04/19/2024$1.20$1.16-3.33%$1.23$1.1157,463 shs$33.32 million04/18/2024$1.21$1.20-0.83%$1.25$1.1729,552 shs$34.46 million04/17/2024$1.22$1.21-0.82%$1.26$1.1530,871 shs$34.75 million04/16/2024$1.24$1.22-1.61%$1.27$1.1166,891 shs$35.04 million04/15/2024$1.26$1.24-1.59%$1.28$1.2121,914 shs$35.61 millionThe ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now.04/12/2024$1.37$1.26-8.03%$1.32$1.2651,084 shs$36.19 million04/11/2024$1.39$1.37-1.44%$1.41$1.3427,879 shs$39.35 million04/10/2024$1.42$1.39-2.11%$1.45$1.3617,822 shs$39.92 million04/09/2024$1.41$1.42+0.71%$1.42$1.3528,166 shs$40.78 million04/08/2024$1.33$1.41+6.02%$1.41$1.3035,725 shs$40.50 million04/05/2024$1.37$1.33-2.92%$1.37$1.2953,793 shs$38.20 million04/04/2024$1.36$1.37+0.74%$1.43$1.19139,626 shs$39.35 million04/03/2024$1.46$1.36-6.85%$1.44$1.3297,140 shs$39.05 million04/02/2024$1.36$1.46+7.35%$1.76$1.261.09 million shs$41.93 million04/01/2024$1.39$1.36-2.16%$1.39$1.2983,166 shs$39.06 million03/29/2024$1.39$1.39$1.42$1.3830,479 shs$39.92 million03/28/2024$1.40$1.39-0.71%$1.42$1.3830,476 shs$39.92 million03/27/2024$1.40$1.40$1.42$1.3736,520 shs$40.21 million03/26/2024$1.43$1.40-2.10%$1.44$1.3733,433 shs$40.21 million03/25/2024$1.49$1.43-4.03%$1.48$1.3958,824 shs$41.07 million03/22/2024$1.46$1.49+2.05%$1.53$1.4424,171 shs$42.79 million03/21/2024$1.43$1.46+2.10%$1.49$1.4243,033 shs$41.93 million03/20/2024$1.56$1.43-8.33%$1.57$1.41113,825 shs$32.50 million03/19/2024$1.60$1.56-2.50%$1.69$1.5644,476 shs$35.46 million03/18/2024$1.65$1.60-3.03%$1.71$1.40235,998 shs$36.37 million03/15/2024$1.55$1.65+6.45%$1.79$1.55209,090 shs$37.50 million03/14/2024$1.62$1.55-4.32%$1.71$1.42388,902 shs$35.24 million03/13/2024$1.62$1.62$1.74$1.601.19 million shs$36.83 million03/12/2024$1.62$1.62$1.70$1.6132,730 shs$36.82 million03/11/2024$1.65$1.62-1.82%$1.69$1.5529,788 shs$36.82 million Related Companies: AMTX Stock Price Chart OPT Stock Price Chart CLLS Stock Price Chart MOLN Stock Price Chart VXRT Stock Price Chart CRDF Stock Price Chart LIFE Stock Price Chart SGMO Stock Price Chart DBVT Stock Price Chart BLUE Stock Price Chart Receive CYTH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYTH) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.